Related Experiment Video
Updated: Aug 9, 2026

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
Published on: January 15, 2018
Dextran sulphate: an adjuvant for cell-mediated immune responses
High molecular weight dextran sulphate (DS) acts as a potent adjuvant, significantly enhancing cell-mediated delayed-type hypersensitivity immune responses. This immune enhancement was observed in both guinea-pigs and mice, highlighting DS
Area of Science:
- Immunology
- Pharmacology
Background:
- Cell-mediated immunity plays a crucial role in host defense against pathogens.
- Delayed-type hypersensitivity (DTH) is a key component of cell-mediated immunity.
- Adjuvants are substances that augment the immune response to an antigen.
Purpose of the Study:
- To investigate the effect of high molecular weight dextran sulphate (DS) on cell-mediated immune responses.
- To determine if DS can enhance delayed-type hypersensitivity (DTH) in animal models.
- To identify optimal conditions for DS administration to achieve immune augmentation.
Main Methods:
- Assessed DTH using three criteria: footpad swelling, intradermal skin tests, and macrophage migration inhibitory factor (MIF) production.
- Utilized guinea-pigs sensitized with egg albumin (EA) and mice sensitized with EA or sheep red blood cells (SRBC).
- Administered varying doses and timings of DS in relation to antigen sensitization and challenge.
Main Results:
- DS treatment led to strong positive delayed skin tests in guinea-pigs sensitized with EA.
- DS increased MIF production in lymphocytes from mice sensitized with EA.
- DS significantly augmented delayed footpad swelling responses in mice sensitized with SRBC, particularly when administered subcutaneously at the same site as SRBC, up to 6 days prior, with optimal enhancement observed 2 days before SRBC.
Conclusions:
- High molecular weight dextran sulphate (DS) is a potent adjuvant for cell-mediated DTH immune responses.
- DS effectively enhances DTH in both guinea-pigs and mice.
- The timing and route of administration of DS are critical for its adjuvant activity.
More Related Videos
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021